Division 02
Abstract Competition
A platform for original research in health economics, outcomes research and HTA, aligned with the conference theme: From Value to Reimbursement.
Who should take part
Open to the HEOR community
Eligibility details pending
Researchers
Original work in pharmacoeconomics, outcomes research and HTA.
Practitioners
Applied evidence from payers, providers and policy settings.
Industry & Academia
Methods, models and real-world evidence studies.
How it works
From submission to stage
- 01
Review the guidelines
Submission guidelines, word limits and formatting requirements will be published here.
- 02
Prepare your abstract
Align your work with one of the four key discussion themes.
- 03
Submit online
The submission portal will open once confirmed by the Scientific Committee.
- 04
Peer review
Submissions will be reviewed by the Abstract Review Committee.
Key dates
Timeline
All deadlines will be confirmed by the organizing committee.
Submission opens
To be announced
Submission deadline
To be announced
Notification of acceptance
To be announced
Oral presentations
December 6–7, 2026
Themes
Aligned with the conference agenda
- 01Health economics in risk-adjusted capitation models
- 02Real-World Data and evidence for health outcomes
- 03Access and reimbursement for high-cost gene, cell and biologic therapies
- 04Risk-sharing agreements and rare disease funding
FAQ
Questions
Coordinated by the Abstract Review Committee.
Eligible topics will be confirmed by the Scientific Committee. Submissions aligned with the four key discussion themes are expected to be prioritised.
6th Annual Conference
Join us in Riyadh
December 6–7, 2026 · InterContinental Riyadh